Article Information
History
- July 31, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Dr Kristy P Robledo1,*,
- Dr Shilo Lefresne2,
- Dr Yu Yang3,
- Dr Arjun Sahgal4,
- A/Prof Mark B Pinkham5,
- Prof Alan Nichol6,
- Dr Ross Andrew Soo7,
- Dr Ambika Parmar8,
- Dr Fiona Hegi-Johnson9,
- Dr Mark Doherty10,
- Prof Benjamin J Solomon11,
- Dr David Shultz12,
- Dr Ivan WK Tham13,
- Dr Adrian Sacher14,
- Dr Jeremy Tey15,
- Dr Cheng Nang Leong16,
- Dr Wee Yao Koh17,
- Dr Yiqing Huang18,
- Dr Yvonne Ang19,
- Dr Jiali Low20,
- Dr Clement Yong21,
- Dr Mei Chin Lim22,
- Dr Ai Peng Tan23,
- A/Prof Chee Khoon Lee24,
- Dr Cheryl Ho25 and
- the oSimertinib with or without sTereotActic Radiosurgery in egfr non-small cell Lung cancEr with brain metastases (STARLET) Collaboration
- 1NHMRC Clinical Trials Centre, University of Sydney, Australia
- 2BC Cancer Agency, Canada
- 3National University Cancer Institute Singapore
- 4Sunnybrook Health Science Centre, Canada
- 5University of Queensland and Princess Alexandra Hospital, Australia
- 6BC Cancer Agency, Canada
- 7National University Cancer Institute Singapore
- 8Sunnybrook Health Sciences Centre, Canada
- 9Peter MacCallum Cancer Centre, Australia
- 10St Vincents University Hospital, Ireland
- 11Peter MacCallum Cancer Centre, Australia
- 12Princess Margaret Cancer Centre, Canada
- 13Mt Elizabeth Novena Hospital, Singapore
- 14Princess Margaret Cancer Centre, Canada
- 15National University Cancer Institute Singapore
- 16National University Cancer Institute Singapore
- 17National University Cancer Institute Singapore
- 18National University Cancer Institute Singapore
- 19National University Cancer Institute Singapore
- 20National University Cancer Institute Singapore
- 21National University Hospital Singapore
- 22National University Hospital Singapore
- 23National University Hospital, Singapore
- 24NHMRC Clinical Trials Centre, University of Sydney, Australia
- 25BC Cancer Agency, Canada
- ↵*Corresponding author; Kristy.robledo{at}sydney.edu.au; 92-94 Parramatta Road, Camperdown, 2050
Posted July 31, 2023.
A protocol for a systematic review with prospective individual patient data meta-analysis in EGFR mutant NSCLC with brain metastases to assess the effect of SRS + Osimertinib compared to Osimertinib alone: the STARLET collaboration
